Frameworks & Resources

The Knowledge & Methods Library

An examination of how ideas become viable products, how products become reliable systems, and how scientific reasoning, commercial strategy and disciplined execution transform uncertainty into informed decisions.

Products do not succeed through creativity, scientific knowledge or operational efficiency in isolation.

They succeed when these disciplines work together.

A compelling idea must answer a genuine need. A formulation must satisfy measurable requirements. A brand must communicate a credible promise. Manufacturing must reproduce the intended product consistently. Compliance must be supported by evidence that remains traceable throughout the product's life.

These frameworks explore the relationships between those decisions.

They are intended for founders, scientists, strategists, manufacturers, students and organisations seeking a more rigorous way to develop and commercialise products.

How the five frameworks interlock

Not five departments in a queue

These frameworks should be used together, not as five isolated checklists. Commercialisation sets the sequence; formulation defines the product; branding articulates its value; manufacturing reproducibly makes it; compliance assembles the evidence for lawful marketing and traceable operation. Each has its own version-controlled master record, but all use a common Product ID, Market ID, Formula/Design Revision, Packaging Revision and Claims Revision.

Choose a decision

01 · Strategy & Commercialisation

Commercialisation: coordinates the overall lifecycle

Should this product exist, and is it ready to launch?

Key decision record
Stage-gate decision log

Open the commercialisation framework

The frameworks

Five disciplines, read at three depths

Each framework can be read in two minutes (Understand), studied in full (Study) or practised with interactive tools and templates (Apply).

  1. 01

    Strategy & Commercialisation · Moving from opportunity to launch

    Product Commercialisation Readiness Framework

    What must be demonstrated before an idea becomes a commercially viable, manufacturable and market-ready product?

    Nine stages with explicit gates, from opportunity assessment to post-launch optimisation. Commercialisation is the management of interdependent decisions under uncertainty.

  2. 02

    Research & Development · Developing scientifically defensible products

    Formulation Development Framework

    How do we transform a product brief into a stable, safe, reproducible and scientifically defensible formulation?

    Twelve steps from target product profile to a controlled development file, with experimental design, stability, packaging interaction and scale-up treated as part of the formula.

  3. 03

    Brand Strategy · Translating insight into meaningful differentiation

    Branding and Marketing Framework

    How does a business identify a meaningful opportunity and build a distinctive, credible brand around it?

    Ten strategic decisions in order — from the buying situation to governance — so that identity follows strategy and every promise has evidence and a delivery mechanism.

  4. 04

    Operations & Quality · Building controlled, repeatable production systems

    Manufacturing and Quality Framework

    How can a manufacturing operation repeatedly produce conforming products while controlling materials, people, equipment, information and risk?

    Six linked flows and twelve control points, scaled to the risk of a small facility, with traceability in both directions and investigations that follow evidence.

  5. 05

    Regulatory & Governance · Managing obligations, evidence and product traceability

    Compliance and Documentation Framework

    How can an organisation demonstrate that its products, processes, claims and records satisfy the obligations applicable to each market?

    Seven evidence layers, a requirements register and a document-control lifecycle — so that every claim, formula, label and batch can be traced to current evidence for a specific market.

Each framework's controlling question and key decision record

FrameworkIts controlling questionKey decision record
CommercialisationShould this product exist, and is it ready to launch?Stage-gate decision log
FormulationCan it reliably meet the product's specified performance and safety requirements?Approved development report and master formulation
BrandingWho is it for, why should they choose it, and what can we credibly say?Positioning and claims substantiation matrix
ManufacturingCan the process repeatedly produce conforming, traceable product?Master batch record and batch disposition
ComplianceWhat evidence is required for this product in each destination market?Market-specific requirements register and evidence index

Universal decision discipline

Record every major decision the same way

  1. 01Question
  2. 02Options
  3. 03Evidence
  4. 04Assumptions
  5. 05Risk
  6. 06Decision owner
  7. 07Date
  8. 08Revision
  9. 09Re-open trigger

An assumption is not evidence. A result from one laboratory batch is not evidence of commercial process capability. A supplier statement is not the same as an independent safety conclusion. The most valuable habit is to make uncertainty visible early.

Shared toolkit

Templates and governance used by all five

Minimum master-data keys

KeyExample formatRule
Product IDPRD-001Stable across lifecycle, never recycled
Formula revisionFRM-001-R03Changes controlled and linked to test batches
Packaging revisionPKG-001-R02Material, geometry, artwork or closure change tracked
Market IDMKT-KE / MKT-EU / MKT-USLocal regulatory status separate
Claim IDCLM-014-R01Exact wording and evidence version controlled
Batch IDLOT-YYYY-NNNUnique lot and full traceability
Evidence IDEVD-032-R02Authoritative stored record and approvals
Change IDCHG-YYYY-NNNCross-functional impact linked to approvals

The five-question executive review

Before approving an irreversible commitment, ask:

  1. What exactly are we promising and to whom?
  2. What do we know, and what are we merely assuming?
  3. What is the most consequential plausible failure?
  4. What is the smallest reliable experiment or control that reduces that risk?
  5. Who owns the decision, what evidence supports it and what event would reopen it?

A practical 90-day implementation sequence

Days 1–15: Assign IDs, audit existing files, identify owners, define market/product scope and reconstruct a risk-based master requirements register. Days 16–30: Build stage gates and common requirements/claims traceability; standardise templates and evidence indexing. Days 31–60: Pilot the full system on one real or clearly labelled demonstration product; test change impact, material traceability and commercial sensitivities. Days 61–75: Correct process friction, train participants and conduct a mock cross-functional gate review. Days 76–90: Audit one vertical product/lot trail, close critical gaps, publish controlled documentation and schedule review triggers.

Working templates

Ten templates to download

Each includes instructions, field definitions and example entries. Examples are marked ILLUSTRATIVE and describe fictional products.

Reference shelf

Sources and jurisdictional cautions

Each link was checked against the publisher's own site on the date shown. Listing a source is not a claim that every requirement in it applies to every product. Recheck laws, standards and market dates before commercial use.

  1. Statutory regulation

    Regulation (EC) No 1223/2009 on cosmetic products (recast) (opens in a new tab)

    European Union, EUR-Lex. Scope: Cosmetic products made available on the EU market. Consolidated versions incorporate later amendments; check the version in force on your market date.

    Requires a responsible person in the EU, a safety assessment and cosmetic product safety report before placing on the market, a Product Information File, labelling and notification.

  2. Regulatory guidance

    Commission Implementing Decision 2013/674/EU — Guidelines on Annex I (cosmetic product safety report) (opens in a new tab)

    European Commission, EUR-Lex. Scope: EU cosmetic product safety reports.

    Guidance to responsible persons; it does not replace the qualified safety assessor, who alone carries out the safety assessment.

  3. Official regulator information

    Cosmetics & U.S. Law (Modernization of Cosmetics Regulation Act of 2022) (opens in a new tab)

    U.S. Food and Drug Administration. Scope: Cosmetics marketed in the United States. Products that are also drugs (including sunscreens) follow drug rules.

    MoCRA added requirements for adverse event reporting, facility registration and product listing, and safety substantiation, and gave FDA records access and mandatory recall authority. FDA must also establish GMP regulations for cosmetic facilities.

  4. Official regulator information

    Registration & Listing of Cosmetic Product Facilities and Products (opens in a new tab)

    U.S. Food and Drug Administration. Scope: Facilities and responsible persons for cosmetics marketed in the United States; certain small businesses are exempt.

    Facility registration is renewed every two years. Registration and listing are not FDA approval.

  5. Official regulator information

    Questions and Answers: FDA's regulatory actions on over-the-counter sunscreen (opens in a new tab)

    U.S. Food and Drug Administration. Scope: Sunscreens marketed in the United States.

    Sunscreens are regulated as over-the-counter drugs under monograph M020. In 2026 FDA added bemotrizinol as a permitted active ingredient and removed PABA and trolamine salicylate.

  6. National standard

    KS 2937:2021 Cosmetics — Safety of cosmetic products — General requirements (catalogue entry) (opens in a new tab)

    Kenya Bureau of Standards web store. Scope: Cosmetic products in Kenya. Product-specific Kenya and East African Standards also apply (for example to creams, lotions, lip products and oils).

    Listed by KEBS alongside KS ISO 22716 and microbiology standards for cosmetics. The standard itself is sold by KEBS and was not reviewed for this library.

  7. Official regulator information

    Certification Body FAQs (Standardization Mark and Import Standardization Mark) (opens in a new tab)

    Kenya Bureau of Standards. Scope: Products manufactured in or imported into Kenya.

    The Standardization Mark is mandatory for locally manufactured products; the Diamond Mark is voluntary.

  8. Official regulator information

    Pre-Export Verification of Conformity (PVoC) services (opens in a new tab)

    Kenya Bureau of Standards. Scope: Goods imported into Kenya, unless exempted under Legal Notice No. 78 of 2020.

    Imported goods are certified against applicable Kenya standards in the country of origin before shipment; otherwise they face destination inspection and testing.

  9. Official regulator information

    Market Surveillance FAQ (opens in a new tab)

    Kenya Bureau of Standards. Scope: Products on the Kenyan market.

    KEBS can issue warnings, recall products, impose fines, revoke permits or prosecute, depending on the level of non-compliance.

  10. Statutory regulation

    Provisions for Registration and Filing of Cosmetics (SAMR Order No. 35) (opens in a new tab)

    National Medical Products Administration, China. Scope: Cosmetics placed on the market in mainland China, under the Cosmetics Supervision and Administration Regulation (in force 1 January 2021).

    Special cosmetics (including sunscreens) require registration; general cosmetics require filing.

  11. Voluntary standard

    ISO 22716:2007 Cosmetics — Good Manufacturing Practices (GMP) — Guidelines on Good Manufacturing Practices (opens in a new tab)

    International Organization for Standardization. Scope: Production, control, storage and shipment of cosmetic products. Its legal weight depends on jurisdiction and contract.

    Last reviewed and confirmed by ISO in 2022, so this edition remains current.

  12. Pharmaceutical methodology

    ICH Quality Guidelines: Q8(R2) Pharmaceutical Development, Q9(R1) Quality Risk Management, Q10 Pharmaceutical Quality System (opens in a new tab)

    International Council for Harmonisation. Scope: Medicines. Useful as scientific and risk-management methodology; not a legal requirement for cosmetics.

    Q8, Q9 and Q10 are designed to work together to support science- and risk-based approaches to quality.

  13. Voluntary standard (guidance note)

    The process approach in ISO 9001:2015 (opens in a new tab)

    International Organization for Standardization. Scope: Quality management systems in general.

    Explains the process approach, risk-based thinking and the Plan-Do-Check-Act cycle. Check for a newer edition of ISO 9001 before relying on clause references.

Links and summaries last checked 18 November 2026.

Editorial methodology

These frameworks were developed and curated by Shamim Quresh, drawing on her professional practice in product development, formulation, manufacturing, branding and compliance.

They rely on published standards, regulations and established scientific principles, cited where they are used. That research and those publications are the work of their own authors and publishers.

AI tools assisted with drafting, structuring and checking the text, the interactive tools and the templates. Content is reviewed by Shamim before publication, and regulatory references were checked against official sources on the review date shown.

Worked examples, scenarios, results and data are illustrative. They do not describe experiments, tests or studies that Shamim has carried out, and no regulatory assessment of any product has been made.

Want to apply a framework to your own product?

I use these methods in consultancy work on product development, commercialisation, manufacturing and compliance. Tell me what you are building and where it is stuck.